OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Dr Nathan Lack is a Senior Research Scientist at the Vancouver Prostate Centre. He obtained a DPhil in Pharmacology from the University of Oxford and then did a Postdoctoral Fellowship at the Vancouver Prostate Centre with Dr. Emma Guns and Professor Paul Rennie. Nathan became an Assistant Professor at Koç University in the School of Medicine (Istanbul) and was awarded Associate Professorship in 2015. He joined the Vancouver Prostate Centre as an independent researcher in 2017. His laboratory works to better understand the molecular underpinnings of prostate cancer to develop more effectively treatments for this common disease. This work has been published in Genome Biology, Nature, Nature Communications and others. Since it’s initiation, the Lack laboratory has obtained extensive funding from national, international and industrial sources. In addition to his academic research, Nathan previously worked for AnorMED Inc., where he was involved in the development of the FDA-approved therapeutic Plerixafor.
